Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25625851 | 0.99 | TSHR (0.43) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL866754 | 0.96 | BBOX1 (0.47) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16799578 | 0.93 | TSHR (0.46) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16799567 | 0.93 | TSHR (0.46) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16799119 | 0.93 | TSHR (0.46) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16799429 | 0.93 | TSHR (0.46) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16799049 | 0.93 | TSHR (0.46) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL18151862 | 0.93 | TSHR (0.46) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL25578813 | 0.92 | THRB (0.44) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799116 | 0.91 | TSHR (0.47) | BBOX1TSHRTHRBCHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025065051-A1 | PLASMA-MEDIATED POLYMER GRAFTING METHODOLOGY | THE UNIVERSITY OF SYDNEY (AU) | 2025-04-03 | — | — | WO | claimed |
| EP-4520795-A1 | ANTIFOULING MEMBER, MEMBER FOR IN-VITRO DIAGNOSTIC APPARATUS, AND METHOD OF PRODUCING ANTIFOULING MEMBER | CANON KABUSHIKI KAISHA (JP) | 2025-03-12 | — | — | EP | claimed |
| US-20250075095-A1 | ANTIFOULING MEMBER, MEMBER FOR IN-VITRO DIAGNOSTIC APPARATUS, AND METHOD OF PRODUCING ANTIFOULING MEMBER | CANON KABUSHIKI KAISHA (JP) | 2025-03-06 | — | — | US | claimed |
| WO-2023089167-A1 | PHOTOBIOREACTOR WITH AN ADSORBED LAYER OF ANTIFOULING ZWITTERIONIC COPOLYMER | FACELLITATE GMBH (DE) | 2023-05-25 | — | — | WO | claimed |
| US-11535588-B2 | Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid | SPCM SA (FR) | 2022-12-27 | — | — | US | claimed |
| US-20220289672-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SPCM SA (FR) | 2022-09-15 | — | — | US | claimed |
| WO-2026099154-A1 | ADHESIVE DEVICE WITH HIGH BONDING STRENGTH | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026099184-A1 | ANTI-CORROSION ADHESIVE DEVICE | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026099181-A1 | DEVICE CAPABLE OF STAIN-FREE DEBONDING ON DEMAND | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4739839-A1 | DIALDEHYDE POLYMER PRODUCTION PROCESS | SNF Group (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4737529-A1 | ADHESIVE COMPOSITION, ADHESIVE TAPE AND THE USE THEREOF, AND METHOD FOR ELECTRICALLY MODIFYING THE ADHESIVE STRENGTH OF THE ADHESIVE TAPE | TESA SE (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4705407-A1 | INVERSE EMULSION FOR HYDRAULIC FRACTURING | SNF Group (FR) | 2026-03-11 | — | — | EP | disclosed |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2026-02-10 | — | — | US | disclosed |
| WO-2018172683-A1 | METHOD FOR TREATING A SUSPENSION OF SOLID PARTICLES IN WATER USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018172684-A1 | FRACTURING FLUID COMPRISING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID AND HYDRAULIC FRACTURING METHOD | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018172682-A1 | ENHANCED OIL RECOVERY METHOD USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| US-10022998-B2 | Planographic printing plate precursor, method of producing same, and printing method using same | FUJIFILM CORPORATION (JP) | 2018-07-17 | — | — | US | disclosed |
| US-9914788-B2 | Active energy ray-curable composition and antistatic film | FUJIFILM CORPORATION (JP) | 2018-03-13 | — | — | US | disclosed |
| EP-3257685-A1 | LITHOGRAPHIC PRINTING ORIGINAL PLATE, METHOD FOR MANUFACTURING SAME, AND PRINTING METHOD USING SAME | Fujifilm Corporation (JP) | 2017-12-20 | — | — | EP | disclosed |
| US-20170320350-A1 | PLANOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PRODUCING SAME, AND PRINTING METHOD USING SAME | FUJIFILM CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289672-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SFN, H1-2, H1-0 | BBOX1 4421/4885TSHR 3902/4885THRB 3863/4885 |
| US-11535588-B2 | Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid | SFN, H1-2, H1-0 | BBOX1 4421/4885TSHR 3902/4885THRB 3863/4885 |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | FUT7, FUT4, SIGLEC7 | BBOX1 790/4885TSHR 565/4885THRB 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.